LYMPHOMA, FOLLICULAR
Clinical trials for LYMPHOMA, FOLLICULAR explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, FOLLICULAR trials appear
Sign up with your email to follow new studies for LYMPHOMA, FOLLICULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: experimental drug enters human testing
Disease control Not yet recruitingThis early-stage study is testing a new drug called MTM-H-001 for adults with B-cell blood cancers that have returned or stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug, while also checking for early signs that…
Matched conditions: LYMPHOMA, FOLLICULAR
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental drug targets tough blood cancers in early safety trial
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LY4152199 in people with B-cell lymphomas that have returned or didn't respond to previous treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping control the cancer. The study will enro…
Matched conditions: LYMPHOMA, FOLLICULAR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC